Health2047 consist of highly specialized physicians how to have more than ten years of experiences in healthcare.
James Madara:
Dr. James Madara serves as the CEO of the American Medical Association. Jim has valuable experience of addressing strategic, operational and financial challenges at leading medical and biosciences organizations. Jim is passionate about creating a healthcare system that delivers better outcomes for all.
Before joining AMA in 2011, Jim was a CEO of the medical center at the University of Chicago. He has also served as Timmie Professor and chair of the department of pathology and laboratory medicine at Emory University, and professor of pathology at Harvard Medical School. Jim holds a BA from Juniata College, an MD from Hahnemann Medical School, and an honorary MA from Harvard University.
Elizabeth Ronn
Elizabeth serves as Independent Board Director at Health2047 Inc. She is well known for marketing/branding expert, entrepreneur, advisor, and passionate advocate of mission-driven innovation. She co-founded a health and wellness company and is a partner at innovation consulting firm Innofolio. Elizabeth has more than 20 marketing experience at Procter & Gamble, and she was a Vice President of Marketing. Elizabeth holds her BA in Economics, with honors, from Louisiana State University and her MBA from Stanford University. Elizabeth also serves on the board of trustees for the San Francisco Art Institute, is Chair of the Governance Council of WANDA.
Lawrence K. Cohen,
Larry is the CEO of Health2047 Inc. he is an experienced biotechnology leader, and he thrives in the development of drugs and platforms to treat illnesses. Larry has also served as Executive Vice President of Research and Business Development at Kadmon Holdings. He has also served as a President and CEO of San Francisco’s VIA Pharmaceuticals, where he spearheaded efforts to develop small-molecule drugs to treat cardiovascular diseases. He was President and CEO of Fremont-based proteomics company Zyomyx; COO of Menlo Park-based Progenitor, Inc. He earned a Ph.D. degree in Microbiology from the University of Illinois and completed his postdoctoral work in Molecular Biology at the Dana-Farber Cancer Institute and the Department of Biochemistry at Harvard Medical School. He earned his B.A. from Grinnell College.
This article put a light on the boards of directors at health2047. The BOD also includes Ken Sharigian, Ray Bingham, Jesse Ehrenfeld, and Doug Given.
Health2047 